Skip to main content

Advertisement

Log in

Preoperative Low Creatine Kinase as a Poor Prognostic Factor in Patients with Colorectal Cancer

  • Research
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

Abstract

Purpose

This study aimed to evaluate the clinicopathological and prognostic significance of preoperative serum creatine kinase (CK) levels in colorectal cancer.

Methods

This study analyzed 1169 patients with colorectal cancer at stages 0 (n = 35), I (n = 301), II (n = 456), III (n = 339), and IV (n = 38). The CK cut-off value was 52 U/L to predict recurrence based on receiver operative characteristics curve. Clinicopathological factors were compared between the low (< 52 U/L) and high CK groups (≥ 52 U/L). The multivariate analysis evaluated relapse-free survival (RFS) and overall survival (OS) following CK status.

Results

The female sex, elderly age (≥ 75), deep tumor (pT4), and carcinoembryonic antigen (+) were independently associated with low CK status. The recurrent rate was significantly higher in the low CK group than in the high CK group (19.1% vs. 11.7%, p < 0.001). Elderly age, pT4, pN (+), preoperative carbohydrate antigen (CA) 19-9 (+), and low CK status were independent risk factors for RFS. Elderly age, pT4, pN (+), preoperative CA19-9 (+), and low CK status were independent risk factors for OS.

Conclusion

Preoperative low CK status was associated with deep tumors and was a poor prognostic factor in patients with colorectal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Data Availability

No datasets were generated or analysed during the current study.

Abbreviations

CK:

Creatine kinase

CEA:

Carcinoembryonic antigen

CA19-9:

Carbohydrate antigen 19-9

References

  1. Japanese Society for Cancer of the Colon and Rectum. Japanese classification of colorectal, appendiceal, and anal carcinoma: the 3D english edition [secondary publication]. J Anus Rectum Colon. 2019;3:175–95. https://doi.org/10.23922/jarc.2019-018.

    Article  PubMed Central  Google Scholar 

  2. Ushigome M, Shimada H, Miura Y, Nagashima Y, Suzuki T, Kagami S, Kurihara A, Funahashi K. Changing pattern of tumor markers in recurrent colorectal cancer patients before surgery to recurrence: serum p53 antibodies, CA19-9 and CEA. Int J Clin Oncol. 2020;25:622–32. https://doi.org/10.1007/s10147-019-01597-6. Epub 2019 Dec 9 PMID: 31820210.

    Article  CAS  PubMed  Google Scholar 

  3. Suzuki S, Akiyoshi T, Oba K, Oba K, Otsuka F, Tominaga T, Nagasaki T, Fukunaga Y, Ueno M. Comprehensive comparative analysis of prognostic value of systemic inflammatory biomarkers for patients with stage II/III colon cancer. Ann Surg Oncol. 2020;27:844–52. https://doi.org/10.1245/s10434-019-07904-9. Epub 2019 Nov 12 PMID: 31720937.

    Article  PubMed  Google Scholar 

  4. Ishikawa S, Miyoshi N, Fujino S, Fujino S, Ogino T, Takahashi H, Uemura M, Yamamoto H, Mizushima T, Doki Y, Eguchi H. Validation of the conventional Glasgow Prognostic Score and development of the improved Glasgow Prognostic Score in patients with stage 0-III colorectal cancer after curative resection. Ann Gastroenterol Surg. 2021;2021(5):345–53. https://doi.org/10.1002/ags3.12426.eCollection. PMID: 34095725.

    Article  Google Scholar 

  5. Okugawa Y, Toiyama Y, Fujikawa H, Kawamura M, Yasuda H, Yokoe T, Mochiki I, Okita Y, Ohi M, Nakatani K. Cumulative perioperative lymphocyte/C-reactive protein ratio as a predictor of the long-term outcomes of patients with colorectal cancer. Surg Today. 2021;51:1906–17. https://doi.org/10.1007/s00595-021-02291-9. Epub 2021 May 5PMID: 33954875.

    Article  CAS  PubMed  Google Scholar 

  6. Lin N, Li J, Yao X, Zhang X, Liu G, Zhang Z, Weng S. Prognostic value of neutrophil-to-lymphocyte ratio in colorectal cancer liver metastasis: A meta-analysis of results from multivariate analysis. Int J Surg. 2022. https://doi.org/10.1016/j.ijsu.2022.106959.

    Article  PubMed  Google Scholar 

  7. Sato R, Oikawa M, Kakita T, Okada T, Abe T, Tsuchiya H, Akazawa N, Ohira T, Harada Y, Okano H, Ito K, Tsuchiya T. A decreased preoperative platelet-to-lymphocyte ratio, systemic immune-inflammation index, and pan-immune-inflammation value are associated with the poorer survival of patients with a stent inserted as a bridge to curative surgery for obstructive colorectal cancer. Surg Today. 2023;53:409–19. https://doi.org/10.1007/s00595-022-02575-8. Epub 2022 Aug 20 PMID: 35987967.

    Article  CAS  PubMed  Google Scholar 

  8. Domenico T, Rita A, Giacomo S, Diego A, Thelma P, Mariana G, Giampaolo N, Francesco N, Maria G, Francesco F, Bruno B, Marco M, Diana C. Salivary biomarkers for diagnosis of acute myocardial infarction: a systematic review. Int J Cardiol. 2023. https://doi.org/10.1016/j.ijcard.2022.09.043.

    Article  PubMed  Google Scholar 

  9. Yan YB. Creatine kinase in cell cycle regulation and cancer. Amino Acids. 2016;48:1775–84. https://doi.org/10.1007/s00726-016-2217-0. Epub 2016 Mar 28 PMID: 27020776.

    Article  CAS  PubMed  Google Scholar 

  10. Kazak L, Cohen P. Creatine metabolism: energy homeostasis, immunity and cancer biology. Nat Rev Endocrinol. 2020;16:421–36. https://doi.org/10.1038/s41574-020-0365-5. Epub 2020 Jun 3 PMID: 32493980.

    Article  PubMed  Google Scholar 

  11. Liu L, He Y, Li L, Zhou P, Zhu Y, Tang H, Huang Y, Li W, Zhang L. Lactate dehydrogenase and creatine kinase as poor prognostic factors in lung cancer: a retrospective observational study. PLoS ONE. 2017. https://doi.org/10.1371/journal.pone.0182168.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Takamori S, Toyokawa G, Shimokawa M, Kinoshita F, Kozuma Y, Matsubara T, Haratake N, Akamine T, Hirai F, Tagawa T, Oda Y, Maehara Y. A novel prognostic marker in patients with non-small cell lung cancer: musculo-immuno-nutritional score calculated by controlling nutritional status and creatine kinase. J Thorac Dis. 2019;11:927–35. https://doi.org/10.21037/jtd.2019.01.76. PMID: 31019782.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Murayama K, Suzuki T, Yajima S, Oshima Y, Nanami T, Shiratori F, Shimada H. Preoperative low serum creatine kinase is associated with poor overall survival in the male patients with esophageal squamous cell carcinoma. Esophagus. 2022;19:105–12. https://doi.org/10.1007/s10388-021-00866-6. Epub 2021 Aug 3. PMID: 34346010.

    Article  PubMed  Google Scholar 

  14. Yamazaki N, Oshima Y, Shiratori F, Nanami T, Suzuki T, Yajima S, Funahashi K, Shimada H. Prognostic significance of preoperative low serum creatine kinase levels in gastric cancer. Surg Today. 2022;52:1551–9. https://doi.org/10.1007/s00595-022-02505-8.

    Article  CAS  PubMed  Google Scholar 

  15. Brierley JD, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumors. 8th ed. Malden, MA: Wiley-Blackwell; 2016.

    Google Scholar 

  16. Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ formedical statistics. Bone Marrow Transplant. 2013;48:452–8. https://doi.org/10.1038/bmt.2012.244. Epub 2012 Dec 3 PMID: 23208313.

    Article  CAS  PubMed  Google Scholar 

  17. Muccini AM, Tran NT, de Guingand DL, Philip M, Della Gatta PA, Galinsky R, Sherman LS, Kelleher MA, Palmer KR, Berry MJ, Walker DW, Snow RJ, Ellery SJ. Creatine metabolism in female reproduction, pregnancy and newborn health. Nutrients. 2021;13:490. https://doi.org/10.3390/nu13020490.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Zhang Y, Li H, Wang X, Gao X, Liu X. Regulation of T cell development and activation by creatine kinase B. PLoS ONE. 2009. https://doi.org/10.1371/journal.pone.0005000.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Chang CC, Liou CB, Su MJ, Lee YC, Liang CT, Ho JL, Tsai HW, Yen TH, Chu FY. Creatine kinase (CK)-MB-to-total-CK ratio: a laboratory indicator for primary cancer screening. Asian Pac J Cancer Prev. 2015;16:6599–603. https://doi.org/10.7314/apjcp.2015.16.15.6599. PMID: 26434881.

    Article  PubMed  Google Scholar 

  20. Chen C, Lin X, Lin R, Huang H, Lu F. A high serum creatine kinase (CK)-MB-to-total-CK ratio in patients with pancreatic cancer: a novel application of a traditional marker in predicting malignancy of pancreatic masses? World J Surg Oncol. 2023. https://doi.org/10.1186/s12957-023-02903-3.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank Seiko Otsuka (Toho University) for preparing the ethical documents. Additionally, we would like to thank MARUZEN-YUSHODO Co., Ltd. (https://kw.maruzen.co.jp/kousei-honyaku/) for the English language editing.

Funding

No funding was received for this work.

Author information

Authors and Affiliations

Authors

Contributions

MU, HS, and K conceived and designed the current study. MU, TK, YM, KY, TS, SK, and AK contributed to the acquisition of the patient’s clinicopathological data. MU and HSH analyzed the patient data. MU and HS drafted the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Hideaki Shimada.

Ethics declarations

Ethics Approval

This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Toho University Omori Medical Center (#M21320 21039 20200 30196 19056 18002).

Consent to Participate

The participants were given the opportunity to decline to be enrolled in the study (opt-out).

Competing Interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 165 KB)

Supplementary file2 (PDF 165 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ushigome, M., Shimada, H., Kaneko, T. et al. Preoperative Low Creatine Kinase as a Poor Prognostic Factor in Patients with Colorectal Cancer. J Gastrointest Canc (2024). https://doi.org/10.1007/s12029-024-01069-9

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12029-024-01069-9

Keywords

Navigation